Akums Q2 FY27: revenue up 31.9% to Rs 1,342 cr, PAT up 168.3% to Rs 115 cr
Q2 FY27 revenue up 31.9% to Rs 1,342 cr, EBITDA up 106.1% to Rs 195 cr, PAT up 168.3% to Rs 115 cr.
By ScoutQuest · · 1 min read
- Q2 FY27 Revenue
- revenue up 31.9% to Rs 1,342 cr
- Q2 FY27 EBITDA
- EBITDA up 106.1% to Rs 195 cr
- Q2 FY27 PAT
- PAT up 168.3% to Rs 115 cr
- Period
- Q2 FY27 and H1 FY27
- Positioning
- Akums presents itself as a CDMO-led manufacturer with more than two decades of experience, plants at Haridwar, Kotdwar, Baddi, Roorkee and Noida, and CDMO at 83.1% of Q2 FY27 revenue.
📈 Q2 FY27 consolidated revenue was Rs 1,342 cr, up 31.9% year on year, with total income of Rs 1,371 cr (+30.6%); EBITDA rose 106.1% to Rs 195 cr at a 14.5% margin and PAT rose 168.3% to Rs 115 cr at an 8.4% margin.
📈 For H1 FY27 the presentation prints revenue of Rs 2,509 cr (+22.9%), EBITDA of Rs 369 cr (+65.3%) and PAT of Rs 216 cr (+100.7%); CDMO was 82.9% of H1 revenue against 83.1% in Q2.
📉 Not every line grew: API revenue fell 35.3% year on year to Rs 29 cr in Q2 FY27 with API EBITDA at minus Rs 6 cr, and trade generics revenue fell 5.4% to Rs 23 cr; management states domestic and international branded margins were lower year on year although they improved sequentially.
📉 Management attributes the quarter to double-digit CDMO volume growth with capacity utilisation above 50%, API prices rising in Q2 at a slower pace and API losses curtailed significantly; it says trade generics continues to break even.
Also from Akums Drugs and Pharmaceuticals
Akums Q2 FY27 revenue up 31.9% to ₹1,342 crore; buys Oriflame India's manufacturing business for ₹56 crore
2 Nov 2026
Board approves unaudited results, designates President – Operations as Senior Management Personnel
2 Nov 2026
Senior VP – R&D Sunil Jaiswal resigns; relieved as Senior Management Personnel on October 31, 2026
31 Oct 2026
More numbers
- Revenue, Q2 FY271,342 cr
- Total income, Q2 FY271,371 cr
- EBITDA, Q2 FY27195 cr
- PAT, Q2 FY27115 cr
- EBITDA margin, Q2 FY2714.5%
- Revenue growth YoY, Q2 FY2731.9%
- PAT growth YoY, Q2 FY27168.3%
- Revenue, H1 FY272,509 cr
- PAT, H1 FY27216 cr
- CDMO share of revenue, Q2 FY2783.1%
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.